GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2776 - 2800 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G25473LQ
469
IgG Patient 2 3 mild
G25473LQ
43
IgM Patient 2 3 mild
G25473LQ
247
IgA Patient 3 -180 mild
G25473LQ
275
IgA Patient 3 11 mild
G25473LQ
400
IgG Patient 3 -180 mild
G25473LQ
37
IgM Patient 3 -180 mild
G25473LQ
72
IgA Patient 3 4 mild
G25473LQ
416
IgG Patient 3 11 mild
G25473LQ
48
IgG Patient 3 4 mild
G25473LQ
44
IgM Patient 3 11 mild
G25473LQ
133
IgM Patient 3 4 mild
G25473LQ
144
IgA Patient 4 12 mild
G25473LQ
332
IgG Patient 4 12 mild
G25473LQ
107
IgM Patient 4 12 mild
G25473LQ
201
IgA Patient 1 10 moderate
G25407RZ
425
IgA Patient 1 22 moderate
G25407RZ
388
IgA Patient 1 6 moderate
G25407RZ
349
IgG Patient 1 10 moderate
G25407RZ
22
IgG Patient 1 22 moderate
G25407RZ
24
IgG Patient 1 6 moderate
G25407RZ
23
IgM Patient 1 10 moderate
G25407RZ
34
IgM Patient 1 22 moderate
G25407RZ
48
IgM Patient 1 6 moderate
G25407RZ
31
IgA Patient 2 15 mild
G25407RZ
485

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024